21![Hepatitis C / Hepatitis / Genetics / Antiviral drug / Gilead Sciences / Biology / Chemistry / Hepatitis C and HIV co-infection / MiR-122 / Protease inhibitors / Hepatitis C virus / Darunavir Hepatitis C / Hepatitis / Genetics / Antiviral drug / Gilead Sciences / Biology / Chemistry / Hepatitis C and HIV co-infection / MiR-122 / Protease inhibitors / Hepatitis C virus / Darunavir](/pdf-icon.png) | Add to Reading ListSource URL: aidsinfonet.orgLanguage: English - Date: 2014-10-30 14:31:37
|
---|
22![Hepatitis C / Hepatitis / Genetics / Antiviral drug / Gilead Sciences / Biology / Chemistry / Hepatitis C and HIV co-infection / MiR-122 / Protease inhibitors / Hepatitis C virus / Darunavir Hepatitis C / Hepatitis / Genetics / Antiviral drug / Gilead Sciences / Biology / Chemistry / Hepatitis C and HIV co-infection / MiR-122 / Protease inhibitors / Hepatitis C virus / Darunavir](/pdf-icon.png) | Add to Reading ListSource URL: www.aidsinfonet.orgLanguage: English - Date: 2014-10-30 14:31:37
|
---|
23![Genotype 1 Treatment: Harvoni (Sofosbuvir & Ledipasvir) Genotype 1 Treatment: Harvoni (Sofosbuvir & Ledipasvir)](https://www.pdfsearch.io/img/e3ed5ca6503462371447215d07dcf86d.jpg) | Add to Reading ListSource URL: hcvadvocate.orgLanguage: English - Date: 2014-10-21 18:43:58
|
---|
24![Genotype 1 Treatment: Harvoni (Sofosbuvir & Ledipasvir) Genotype 1 Treatment: Harvoni (Sofosbuvir & Ledipasvir)](https://www.pdfsearch.io/img/6b8d13642d21d74f8752c662f6021cec.jpg) | Add to Reading ListSource URL: www.hcvadvocate.orgLanguage: English - Date: 2014-11-03 17:42:36
|
---|
25![Drugs in Development: Phase 3Genotype 1 – Sovaldi (sofosbuvir)/Ledipasvir Drugs in Development: Phase 3Genotype 1 – Sovaldi (sofosbuvir)/Ledipasvir](https://www.pdfsearch.io/img/e64b44d700cc621a59e80f94d8ae61f4.jpg) | Add to Reading ListSource URL: www.hcvadvocate.orgLanguage: English - Date: 2014-09-18 02:20:21
|
---|
26![Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C Press Release Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C Press Release](https://www.pdfsearch.io/img/945b21c265424e767b606369dac2dd2c.jpg) | Add to Reading ListSource URL: www.hepcassoc.orgLanguage: English - Date: 2014-02-12 14:23:56
|
---|
27![AASLD 2013: 100% of Hard-to-treat Patients Cured with Sofosbuvir/Ledipasvir + Ribavirin or GS-9669 November 3, 2013 AASLD 2013: 100% of Hard-to-treat Patients Cured with Sofosbuvir/Ledipasvir + Ribavirin or GS-9669 November 3, 2013](https://www.pdfsearch.io/img/05b4651c397ac0f923c8cca12e53989d.jpg) | Add to Reading ListSource URL: www.hepcassoc.orgLanguage: English - Date: 2013-11-07 14:20:07
|
---|